Literature DB >> 6410855

Ischemic chiasma syndrome.

K F Lee.   

Abstract

Thirty patients with chiasma syndrome attributed to ischemic processes of various origins are described. The initial diagnosis was made after an investigation based on polytome pneumoencephalography and angiography. This diagnosis was confirmed later with the use of high-resolution computed tomography (CT) and refined angiographic techniques. The ischemic chiasma syndrome may be classified into five pathogenetic categories: (1) mechanical compression of the chiasm secondary to ectatic tortuous arteries; (2) vascular occlusion secondary to atheromatous plaque formation; (3) arachnoiditis with fibrosis; (4) arteritis of various origins; and (5) postpartum necrosis. Sophisticated neurologic procedures including magnification angiography and high-resolution CT are essential in ruling out a mass lesion and correlating the clinical and radiologic findings of this syndrome.

Entities:  

Mesh:

Year:  1983        PMID: 6410855      PMCID: PMC8334972     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  3 in total

Review 1.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

2.  Bitemporal hemianopsia secondary to ischemic chiasmopathy following mechanical thrombectomy.

Authors:  Rohini Rao Sigireddi; Nita Bhat; Subahari Raviskanthan; Peter William Mortensen; Shruthi Harish Bindiganavile; Richard Klucznik; Andrew Go Lee
Journal:  Am J Ophthalmol Case Rep       Date:  2021-08-13

Review 3.  Treatment of empty sella associated with visual impairment: a systematic review of chiasmapexy techniques.

Authors:  Lina Raffaella Barzaghi; Carmine Antonio Donofrio; Pietro Panni; Marco Losa; Pietro Mortini
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.